EFLM WG-Preanalytical phase opinion paper: local validation of blood collection tubes in clinical laboratories

被引:45
作者
Lippi, Giuseppe [2 ]
Cornes, Michael P. [3 ]
Grankvist, Kjell [4 ]
Nybo, Mads [5 ]
Simundic, Ana-Maria [1 ,2 ]
机构
[1] Univ Hosp Sveti Duh, Dept Med Lab Diagnost, Sveti Duh 64, Zagreb 10000, Croatia
[2] Univ Verona, Clin Biochem Sect, I-37100 Verona, Italy
[3] New Cross Hosp, Dept Clin Chem, Wolverhampton, W Midlands, England
[4] Umea Univ, Clin Chem, Dept Med Biosci, Umea, Sweden
[5] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark
关键词
blood collection; blood tubes; errors; preanalytical; variability; venipuncture; CONSENSUS STATEMENT; EUROPEAN FEDERATION; WORKING-GROUP; CHEMISTRY; MEDICINE; QUALITY; SERUM;
D O I
10.1515/cclm-2015-1274
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The selection or procurement of blood collection devices in healthcare facilities is often an underestimated issue. This is probably due to different factors including the lack of knowledge of policymakers, hospital administrators and even laboratory managers about the importance of preanalytical quality and phlebotomy process, as well as to the absence of reliable guidelines or recommendations on how to precisely assess the quality of blood collection devices around the globe. With the awareness that a gap remains between manufacturers' and local validation of blood collection devices, the Working Group for Preanalytical Phase (WG-PRE) of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) has drafted a consensus document aimed to provide a set of essential requisites, technical criteria (e.g. presence of physical defects, malfunctioning, safety problems) and clinical issues for supporting laboratory professionals in organization blood collection tubes tenders and validating new devices before local routine implementation. The laboratory professionals should also make sure that the tenders accurately and strictly define the responsibilities for validation experiments and the potential consequences in the case the validation outcome shows that tubes due not fulfill the expectations.
引用
收藏
页码:755 / 760
页数:6
相关论文
共 25 条
[1]  
[Anonymous], 2005, ISO 9000
[2]  
[Anonymous], 2010, GP34A CLSI
[3]  
[Anonymous], 2010, ESTABLISHING VERIFYI
[4]   Interferences from blood collection tube components on clinical chemistry assays [J].
Bowen, Raffick A. R. ;
Remaley, Alan T. .
BIOCHEMIA MEDICA, 2014, 24 (01) :31-44
[5]   Optimizing the purification and analysis of miRNAs from urinary exosomes [J].
Channavajjhala, Sarath Kiran ;
Rossato, Marzia ;
Morandini, Francesca ;
Castagna, Annalisa ;
Pizzolo, Francesca ;
Bazzoni, Flavia ;
Olivieri, Oliviero .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (03) :345-354
[6]  
Clinical and Laboratory Standards Institute (CLSI), 2010, GP39A6 CLSI
[7]   Circulating cell free DNA: Preanalytical considerations [J].
El Messaoudi, Safia ;
Rolet, Fanny ;
Mouliere, Florent ;
Thierry, Alain R. .
CLINICA CHIMICA ACTA, 2013, 424 :222-230
[8]   Regulation of in vitro diagnostics (IVDs) for use in clinical diagnostic laboratories: towards the light or dark in clinical laboratory testing? [J].
Favaloro, Emmanuel J. ;
Plebani, Mario ;
Lippi, Giuseppe .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (12) :1965-1973
[9]   Comparison of Whole Blood RNA Preservation Tubes and Novel Generation RNA Extraction Kits for Analysis of mRNA and MiRNA Profiles [J].
Haentzsch, Madlen ;
Tolios, Alexander ;
Beutner, Frank ;
Nagel, Dorothea ;
Thiery, Joachim ;
Teupser, Daniel ;
Holdt, Lesca M. .
PLOS ONE, 2014, 9 (12)
[10]   Application of failure mode and effects analysis in a clinical chemistry laboratory [J].
Jiang, Yuanyuan ;
Jiang, Hongmin ;
Ding, Siyi ;
Liu, Qin .
CLINICA CHIMICA ACTA, 2015, 448 :80-85